Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Behavioral Addiction (January/February/March) | 2024

View Archived Issues

Learning Objectives, Behavioral Addiction, CATR, January/February/March 2024

February 7, 2024

After reading these articles, you should be able to...

Food Addiction and Related Disorders

February 1, 2024

Heidi Moawad, MD and Noah Capurso, MD, MHS

Often lumped in with binge-eating disorder, food addiction is an emerging concept in the field of behavioral addictions.

Diagnosis and Treatment of Gambling Addiction

February 1, 2024

Timothy Fong, MD.

Gambling disorder is much more prevalent than many providers realize, and it is a condition that is rarely screened for, let alone treated, by mental health professionals. Here, Dr. Fong reviews the topic, walks us through how to take a good gambling history, make a diagnosis, and how to provide the best treatment.

Evaluating and Treating Patients With Problematic Sexual Behaviors

February 1, 2024

Amos Turner, MD.

Sexual addictions are rarely discussed with patients, even among addiction specialists. Societal taboos, social norms, and stigma can make it difficult for patients to discuss sexual issues with their providers. In this interview, Dr. Turner gives us tips in history gathering and covers what you need to know about diagnosis and treatment.

A Spotlight on Two Emerging Nootropics

February 10, 2024

Jeremy Weleff, DO., Akhil Anand, MD., and Julian J. Raffoul, MD, PhD.

Nootropics are a broad class of medications encompassing many different mechanisms of action that are marketed as cognitive enhancers. Not only do most nootropics lack evidence of efficacy, but some can have dangerous side effects and addictive potential. Here, we discuss some of the most concerning nootropics being widely used today.

Deep Brain Stimulation for Severe Alcohol Use Disorder

February 1, 2024

Maryam Soltani, MD, PhD.

Despite its high prevalence, morbidity, and mortality, our treatment options for alcohol use disorder are limited. Severe alcohol use disorder can be especially challenging to treat. Here, researchers demonstrate the efficacy and feasibility of a novel treatment option: deep brain stimulation.

Extended-Release Buprenorphine for Opioid Use Disorder in Correctional Settings

February 1, 2024

Eli Neustadter, MD, MSc.

Incarcerated individuals with opioid use disorder are at an especially heightened risk of adverse outcomes. The period immediately following release is a particularly vulnerable time, with a much elevated risk of fatal overdose. In this study, investigators report on the use of extended-release injectable buprenorphine in a correctional setting.